ANVISA
Enhancing Efficiency: ANVISA’s IN 290/2024 Streamlines Regulatory Processes
Globalization and the rapid advance of new technologies have presented a major challenge to regulators worldwide. Highly complex regulatory developments and the globalized production chain have advanced much faster than the availability of financial and human resources in most regulatory authorities.
